Cite
APA Citation
Shih, Y. T., Cortes, J. E., & Kantarjian, H. M. (2019). treatment value of second-generation BCR-ABL1 tyrosine kinase inhibitors compared with imatinib to achieve treatment-free remission in patients with chronic myeloid leukaemia: a modelling study. Lancet, 6(8), e398–e408. http://access.bl.uk/ark:/81055/vdc_100088833125.0x000006